Pueroside ACAS# 100692-52-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
| Cas No. | 100692-52-2 | SDF | Download SDF |
| PubChem ID | N/A | Appearance | Powder |
| Formula | C29H34O14 | M.Wt | 606.6 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Structure Identification | Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012 Jan;41(1):32-42.Identification of major components of traditional Chinese medicine Naodesheng tablet by HPLC-DAD-MS(n).[Pubmed: 22419461]To identify the major components of traditional Chinese medicine Naodesheng tablet.
|
Pueroside A Dilution Calculator
Pueroside A Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.6485 mL | 8.2427 mL | 16.4853 mL | 32.9707 mL | 41.2133 mL |
| 5 mM | 0.3297 mL | 1.6485 mL | 3.2971 mL | 6.5941 mL | 8.2427 mL |
| 10 mM | 0.1649 mL | 0.8243 mL | 1.6485 mL | 3.2971 mL | 4.1213 mL |
| 50 mM | 0.033 mL | 0.1649 mL | 0.3297 mL | 0.6594 mL | 0.8243 mL |
| 100 mM | 0.0165 mL | 0.0824 mL | 0.1649 mL | 0.3297 mL | 0.4121 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Momordicine V
Catalog No.:BCN8751
CAS No.:1012315-36-4
- Cassiaglycoside II
Catalog No.:BCN8750
CAS No.:2241081-56-9
- Atractylochromene
Catalog No.:BCN8749
CAS No.:203443-33-8
- Leachianol G
Catalog No.:BCN8748
CAS No.:164204-62-0
- Marginatoxin
Catalog No.:BCN8747
CAS No.:1422536-56-8
- Polygalasaponin XXXV
Catalog No.:BCN8746
CAS No.:184479-28-5
- Momordicine II
Catalog No.:BCN8745
CAS No.:91590-75-9
- Quercetin 3-Caffeylrobinobioside
Catalog No.:BCN8744
CAS No.:957110-26-8
- Tessaric acid
Catalog No.:BCN8743
CAS No.:58142-10-2
- Ganoderic acid R
Catalog No.:BCN8489
CAS No.:103963-39-9
- L-Fucitol
Catalog No.:BCN8464
CAS No.:13074-06-1
- 1,3,6-Trihydroxy-2-methylanthraquinone 3-O-alpha-L-rhamnosyl-(1->2)-beta-D-glucoside
Catalog No.:BCN8732
CAS No.:87686-88-2
- Leachianol F
Catalog No.:BCN8753
CAS No.:164123-50-6
- Polygalasaponin E
Catalog No.:BCN8754
CAS No.:882664-72-4
- Yuanhuanin
Catalog No.:BCN8756
CAS No.:83133-14-6
- Ampelopsin G
Catalog No.:BCN8757
CAS No.:151487-09-1
- Torosachrysone 8-O-beta-gentiobioside
Catalog No.:BCN8758
CAS No.:94356-13-5
- ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid
Catalog No.:BCN8759
CAS No.:55483-24-4
- Microgrewiapine A
Catalog No.:BCN8760
CAS No.:1420777-30-5
- Rhamnocitrin 3-glucoside
Catalog No.:BCN8761
CAS No.:41545-37-3
- (1,5E,11E)-tridecatriene-7,9-diyne-3,4-diacetate
Catalog No.:BCN8762
CAS No.:201012-14-8
- 3,7,23,24-tetrahydroxycucurbita-5,25-dien-19-al
Catalog No.:BCN8763
CAS No.:1446447-97-7
- Orientalide
Catalog No.:BCN8764
CAS No.:72704-05-3
- Rhamnocitrin 3-apiosyl-(1→2)-glucoside
Catalog No.:BCN8765
CAS No.:148031-68-9
[Identification of major components of traditional Chinese medicine Naodesheng tablet by HPLC-DAD-MS(n)].[Pubmed:22419461]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012 Jan;41(1):32-42.
OBJECTIVE: To identify the major components of traditional Chinese medicine Naodesheng tablet. METHODS: A HPLC-DAD-MS(n) based method was developed to analyze and identify the major components of Naodesheng tablet. Separation was performed on an Agilent Zorbax SB-C(18) column (4.6 mm X 250 mm, i.d, 5 mum) with mobile phase consisting of water with 0.05 % formic acid and acetonitrile as gradient eluent at the flow rate of 0.5 ml.min(-1). RESULTS: A total of 43 components were detected, among which 22 were identified by comparing their UV absorption profiles, the information of molecular Glucosyl puerarin weights, and structures provided by ESI-MS(n) with those of available standards and reference data, such as Safflor yellow A, 4'-O-Glucosyl puerarin, 3'-hydroxypuerarin, Genistein-8-C-apiosyl (1-6) glucoside, Puerarin, 6"-O-xylosyl puerarin, 6"-O-apiosyl puerarin, 3'-methoxy puerarin, 3'-methoxy-6"-o-xylosyl puerarin, Daidzin, Genistin, Pueroside A, Notoginsenoside R(1), Ginsenoside Re, Ginsenoside Rg1,Daidzein,Biochanin A,Ginsenoside Rb(1), Ginsenoside Rc, Ginsenoside Rb(2), Ginsenoside Rb(3), Ginsenoside Rd. CONCLUSION: The proposed method can identify the main components of Naodesheng tablet and provide information for the quality control of this medicine.
